Abstract: The present disclosure relates to the field of implantable intraocular drug delivery devices. In particular, the present disclosure relates to intraocular drug delivery devices integrated into a capsular tension ring (“CTR”) that is designed for implantation in the capsule or the ciliary sulcus during a cataract extraction and intraocular lens implantation procedure.
Abstract: Intraocular pressure sensors, systems, and methods of use. Implantable intraocular pressure sensing devices that are hermetically sealed and adapted to wirelessly communicate with an external device. The implantable devices can include a hermetically sealed housing, the hermetically sealed housing including therein: an antenna in electrical communication with a rechargeable power source, the rechargeable power source in electrical communication with an ASIC, and the ASIC in electrical communication with a pressure sensor.
Abstract: Intraocular lenses that include a central portion and one or more peripheral portions. The IOLs includes a sensor housing and a communication member, both of which are secured to the central portion.
Type:
Grant
Filed:
April 1, 2019
Date of Patent:
March 14, 2023
Assignee:
Qura, Inc.
Inventors:
Douglas P. Adams, Jean-Noel Fehr, Amitava Gupta
Abstract: Intraocular pressure sensors, systems, and methods of use. Implantable intraocular pressure sensing devices that are hermetically sealed and adapted to wirelessly communicate with an external device. The implantable devices can include a hermetically sealed housing, the hermetically sealed housing including therein: an antenna in electrical communication with a rechargeable power source, the rechargeable power source in electrical communication with an ASIC, and the ASIC in electrical communication with a pressure sensor.
Type:
Application
Filed:
September 30, 2022
Publication date:
January 26, 2023
Applicant:
Qura, Inc.
Inventors:
Douglas P. ADAMS, Celso TELLO, Marcel David ACKERMANN, Jean-Noël FEHR
Abstract: Methods based on providing monitoring services and access to information to caregivers, patients with implanted pressure sensors and distributors.
Abstract: Intraocular pressure sensors, systems, and methods of use. Implantable intraocular pressure sensing devices that are hermetically sealed and adapted to wirelessly communicate with an external device. The implantable devices can include a hermetically sealed housing, the hermetically sealed housing including therein: an antenna in electrical communication with a rechargeable power source, the rechargeable power source in electrical communication with an ASIC, and the ASIC in electrical communication with a pressure sensor.
Type:
Grant
Filed:
May 31, 2017
Date of Patent:
November 15, 2022
Assignee:
Qura, Inc.
Inventors:
Douglas P. Adams, Celso Tello, Marcel David Ackermann, Jean-Noël Fehr
Abstract: Intraocular pressure sensing devices and methods of use. The intraocular pressure sensing devices may include one or more calibration sensors that are adapted to sense fibrotic growth over the implant post-implantation. Methods can take into account the amount of fibrosis over the implant, and its effect on IOP, when calculating the subject's IOP. Additionally, methods herein can calculate IOP while factoring in blink-induced variation in IOP.
Abstract: Intraocular pressure sensors, systems, and methods of use. Implantable intraocular pressure sensing devices that are hermetically sealed and adapted to wirelessly communicate with an external device. The implantable devices can include a hermetically sealed housing, the hermetically sealed housing including therein: an antenna in electrical communication with a rechargeable power source, the rechargeable power source in electrical communication with an ASIC, and the ASIC in electrical communication with a pressure sensor.
Type:
Application
Filed:
May 31, 2017
Publication date:
June 13, 2019
Applicant:
Qura, Inc.
Inventors:
Douglas P. ADAMS, Celso TELLO, Marcel David ACKERMANN, Jean-Noël FEHR